408
Views
0
CrossRef citations to date
0
Altmetric
Review

Analytical Methods for the Detection of Clenbuterol

, &
Pages 437-450 | Published online: 11 Jun 2009

Bibliography

  • British Thoracic Society. British Guideline on the management of asthma. Thorax63 , iv1–121 (2008).
  • EEC, Council Directive 96/22/EC of 29 April 1996 concerning the prohibition on the use in stockfarming of certain substances having a hormonal or thyrostatic action and of β-agonists, and repealing Directives 81/602/EEC, 88/146/EEC and 88/299/EEC. (1996).
  • EEC, Council Regulation (EEC) No 2377/90 of 26 June 1990 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin. (1990).
  • VENTIPULMIN® Syrup, prescribing information. Boehringer Ingelheim Vetmedica, Inc., MO, USA (2001).
  • Rehfeldt C , WeikardR, ReichelK. [The effect of the β-adrenergic agonist clenbuterol on the growth of skeletal muscles of rats]. Arch. Tierernahr.45 , 333–344 (1994).
  • Maltin CA , DeldayMI, HaySM, SmithFG, LobleyGE, ReedsPJ. The effect of the anabolic agent, clenbuterol, on overloaded rat skeletal muscle. Biosci. Rep.7 , 143–149 (1987).
  • Brockway JM , MacRaeJC, WilliamsPE. Side effects of clenbuterol as a repartitioning agent. Vet. Rec.120 , 381–383 (1987).
  • Drug Enforcement Administration. Drugs and chemicals of concern – clenbuterol. US Department of Justice (2007).
  • Parr MK , KöhlerK, GeyerH, GuddatS, SchänzerW. Clenbuterol marketed as dietary supplement. Biomed. Chromatogr.22 , 298–300 (2008).
  • Geyer H , ParrMK, KöhlerK, MareckU, SchänzerW, ThevisM. Nutritional supplements cross-contaminated and faked with doping substances. J. Mass Spectrom.43 , 892–902 (2008).
  • Meyer HH . The illegal practice and resulting risks versus the controlled use of licensed drugs: views on the present situation in Germany. Ann. Rech. Vet.22 , 299–304 (1991).
  • Elliott CT , ShorttHD, KennedyDG, McCaugheyWJ. Monitoring for clenbuterol abuse in N. Ireland 1989–1994. Vet. Q.18 , 41–44 (1996).
  • Kuiper HA , NoordamMY, van Dooren-Flipsen MM, Schilt R, Roos AH. Illegal use of β-adrenergic agonists: European community. J. Anim. Sci.76 , 195–207 (1998).
  • Mitchell GA , DunnavanG. Illegal use of β-adrenergic agonists in the United States. J. Anim. Sci.76 , 208–211 (1998).
  • Barbosa J , CruzC, MartinsJet al. Food poisoning by clenbuterol in Portugal. Food Addit. Contam. 22 , 563–566 (2005).
  • Brambilla G , CenciT, Franconi,Fet al. Clinical and pharmacological profile in a clenbuterol epidemic poisoning of contaminated beef meat in Italy. Toxicol. Lett. 114 , 47–53 (2000).
  • Sporano V , GrassoL, EspositoM, OlivieroG, BrambillaG, LoizzoA. Clenbuterol residues in non-liver containing meat as a cause of collective food poisoning. Vet. Hum. Toxicol.40 , 141–143 (1998).
  • Brambilla G , LoizzoA, FontanaL, StrozziM, GuarinoA, SopranoV. Food poisoning following consumption of clenbuterol-treated veal in Italy. JAMA278 , 635 (1997).
  • Pulce C , LamaisonD, KeckG, BostvironnoisC, NicolasJ, DescotesJ. Collective human food poisonings by clenbuterol residues in veal liver. Vet. Hum. Toxicol.33 , 480–481 (1991).
  • Salleras L , DominguezA, MataE, TabernerJL, MoroI, SalvaP. Epidemiologic study of an outbreak of clenbuterol poisoning in Catalonia, Spain. Public Health Rep.110 , 338–342 (1995).
  • Martinez-Navarro JF . Food poisoning related to consumption of illicit β-agonist in liver. Lancet336 , 1311 (1990).
  • Smith DJ . Stereochemical composition of clenbuterol residues in edible tissues of swine. J. Agric. Food Chem.48 , 6036–6043 (2000).
  • Salquebre G , BressonM, VillainM, CirimeleV, KintzP. Clenbuterol determination in calf hair by UPLC-MS-MS: case report of a fraudulent use for cattle growth. J. Anal. Toxicol.31 , 114–118 (2007).
  • Kintz P , Dumestre-TouletV, JameyC, CirimeleV, LudesB. Doping control for β-adrenergic compounds through hair analysis. J. Forensic Sci.45 , 170–174 (2000).
  • Internationale FE. Equine Anti-Doping and Medication Control Rules. 1–23 (2006).
  • Dumestre-Toulet V , CirimeleV, LudesB, GrombS, KintzP. Hair analysis of seven bodybuilders for anabolic steroids, ephedrine, and clenbuterol. J. Forensic Sci.47 , 211–214 (2002).
  • Machnik M , GeyerH, HorningS, BreidbachA, DelahautP, SchänzerW. Long-term detection of clenbuterol in human scalp hair by gas chromatography-high-resolution mass spectrometry. J. Chromatogr. B Biomed. Sci. Appl.723 , 147–155 (1999).
  • Wingert WE , MundyLA, NelsonL, WongSC, CurtisJ. Detection of clenbuterol in heroin users in twelve postmortem cases at the Philadelphia medical examiner‘s office. J. Anal. Toxicol.32 , 522–528 (2008).
  • Bilkoo P , ThomasJ, RiddleCD, KagaoanG. Clenbuterol toxicity: an emerging epidemic. A case report and review. Conn. Med.71 , 89–91 (2007).
  • Werder G , AroraG, FrischA, AslamS, ImaniF, MissriJ. Clenbuterol-contaminated heroin: cardiovascular and metabolic effects. A case series and review. Conn. Med.70 , 5–11 (2006).
  • Gleixner A , MeyerHH, VosA, AylanO. Clenbuterol as a marker in baits for oral vaccination of dogs against rabies. Vet. Rec.143 , 65–68 (1998).
  • Rabiet M , TogolaA, BrissaudF, SeidelJL, BudzinskiH, Elbaz-PoulichetF. Consequences of treated water recycling as regards pharmaceuticals and drugs in surface and ground waters of a medium-sized Mediterranean catchment. Environ. Sci. Technol.40 , 5282–5258 (2006).
  • Bres J , ClauzelAM, PistreMC, RachmatH, BressolleF. [Metabolism of β-adrenergic substances. Therapeutic implications]. Bull. Eur. Physiopathol. Respir.21 , 19S–34S (1985).
  • Council of Europe. Clenbuterol hydrochloride. In: European Pharmacopoeia. Deutscher Apotheker Verlag, Stuttgart, Germany, 1805–1806 (2008).
  • Clarke‘s Analysis of Drugs and Poisons (3rd Edition). Moffat AC, Osselton MD, Widdop B (Eds). Pharmaceutical Press, London, UK (2004).
  • Haughey SA , BaxterGA, ElliottCT, PerssonB, JonsonC, BjurlingP. Determination of clenbuterol residues in bovine urine by optical immunobiosensor assay. J. AOAC Int.84 , 1025–1030 (2001).
  • Hagedorn HW , ZuckS, SchulzR. Detection of clenbuterol (Ventipulmin®) in the horse. Journal of Veterinary Medicine Series a-Zentralblatt Fur Veterinarmedizin Reihe a-Physiology Pathology Clinical Medicine42 , 209–219 (1995).
  • Xu T , WangBM, ShengW, LiQX, ShaoXL, LiJ. Application of an enzyme-linked immunosorbent assay for the detection of clenbuterol residues in swine urine and feeds. J. Environ. Sci. Health B42 , 173–177 (2007).
  • Polettini A , SeguraJ, GonzalezG, de la Torre X, Montagna M. Clenbuterol and β-adrenergic drugs detected in hair of treated animals by ELISA. Clin. Chem.41 , 945–946 (1995).
  • Adam A , GervaisN, PanoyanAet al. Detection of clenbuterol residues in hair. Analyst 119 , 2663–2666 (1994).
  • BIOO Scientific Corp. β-agonist ELISA Test Kit Manual (2007).
  • Meyer HH , RinkeL, DurschI. Residue screening for the β-agonists clenbuterol, salbutamol and cimaterol in urine using enzyme immunoassay and high-performance liquid chromatography. J. Chromatogr.564 , 551–556 (1991).
  • Roda A , ManettaAC, PiazzaF, SimoniP, LelliR. A rapid and sensitive 384-microtiter wells format chemiluminescent enzyme immunoassay for clenbuterol. Talanta52 , 311–318 (2000).
  • Meyer HH , RinkeLM. The pharmacokinetics and residues of clenbuterol in veal calves. J. Anim. Sci.69 , 4538–4544 (1991).
  • Li Z , JianL, WangH, CuiY. Flow injection chemiluminescent determination of clenbuterol using GoldMag particles as carrier. Food Addit. Contam.24 , 21–25 (2007).
  • Peng Z , Bang-CeY. Small molecule microarrays for drug residue detection in foodstuffs. J. Agric. Food Chem.54 , 6978–6983 (2006).
  • Zou M , GaoH, LiJ, XuF, WangL, JiangJ. Rapid determination of hazardous compounds in food based on a competitive fluorescence microsphere immunoassay. Anal. Biochem.374 , 318–324 (2008).
  • Johansson MA , HellenasKE. Matrix effects in immunobiosensor determination of clenbuterol in urine and serum. Analyst129 , 438–442 (2004).
  • Lai W , XuY, FungDY, XiongY. Development of a lateral-flow assay for rapid screening of the performance-enhancing sympathomimetic drug clenbuterol used in animal production; food safety assessments. Asia Pac. J. Clin. Nutr.16(Suppl. 1) , 106–110 (2007).
  • Zhang GP , WangXN, YangJFet al. Development of an immunochromatographic lateral flow test strip for detection of β-adrenergic agonist clenbuterol residues. J. Immunol. Methods 312 , 27–33 (2006).
  • Danyi S , DegandG, DuezC, GranierB, Maghuin-RogisterG, ScippoML. Solubilisation and binding characteristics of a recombinant β2-adrenergic receptor expressed in the membrane of Escherichia coli for the multianalyte detection of β-agonists and antagonists residues in food-producing animals. Anal. Chim. Acta589 , 159–165 (2007).
  • Engelmann MD , HinzD, WenclawiakBW. Solid-phase micro extraction (SPME) and headspace derivatization of clenbuterol followed by GC-FID and GC-SIMMS quantification. Anal. Bioanal. Chem.375 , 460–464 (2003).
  • Gallo P , BrambillaG, NeriB, FioriM, TestaC, SerpeL. Purification of clenbuterol-like β2-agonist drugs of new generation from bovine urine and hair by alpha1-acid glycoprotein affinity chromatography and determination by gas chromatography-mass spectrometry. Anal. Chim. Acta587 , 67–74 (2007).
  • Henze MK , OpfermannG, Spahn-LangguthH, SchänzerW. Screening of β-2 agonists and confirmation of fenoterol, orciprenaline, reproterol and terbutaline with gas chromatography-mass spectrometry as tetrahydroisoquinoline derivatives. J. Chromatogr. B Biomed. Sci. Appl.751 , 93–105 (2001).
  • Damasceno L , VenturaR, OrtunoJ, SeguraJ. Derivatization procedures for the detection of β(2)-agonists by gas chromatographic/mass spectrometric analysis. J. Mass Spectrom.35 , 1285–1294 (2000).
  • Damasceno L , VenturaR, CardosoJ, SeguraJ. Diagnostic evidence for the presence of β-agonists using two consecutive derivatization procedures and gas chromatography-mass spectrometric analysis. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.780 , 61–71 (2002).
  • Abukhalaf IK , von Deutsch DA, Parks BA et al. Comparative analytical quantitation of clenbuterol in biological matrices using GC-MS and EIA. Biomed. Chromatogr.14 , 99–105 (2000).
  • Gonzalez-Gigosos P , Fente-SampayoC, Franco-AbuinC, Cepedα-SaezA, Vazquez-BeldaBI. Effects of frozen storage on the recovery of clenbuterol from urine samples for official control. Food Addit. Contam.19 , 1010–1014 (2002).
  • Seinsch I . Bestimmung der β-2-agonisten clenbuterol, isoxsuprin, salbutamol und cimaterol in plasma und urin des pferdes. Thesis: Institut für Pharmakologie, Pharmazie und Toxikologie, Veterinärmedizinische Fakultät. Universität Leipzig, Leipzig, Germany (1997).
  • Ventura R , DamascenoL, FarreM, CardosoJ, SeguraJ. Analytical methodology for the detection of β2-agonists in urine by gas chromatography-mass spectrometry for application in doping control. Analytica Chimica Acta418 , 79–92 (2000).
  • Harkins JD , WoodsWE, LehnerAF, FisherM, TobinT. Clenbuterol in the horse: urinary concentrations determined by ELISA and GC/MS after clinical doses. J. Vet. Pharmacol. Ther.24 , 7–14 (2001).
  • Polettini A , GroppiA, RicossaMC, MontagnaM. Gas chromatographic/electron impact mass spectrometric selective confirmatory analysis of clenbuterol in human and bovine urine. Biol. Mass Spectrom.22 , 457–461 (1993).
  • Brunelli C , BicchiC, Di Stilo A, Salomone A, Vincenti M. High-speed gas chromatography in doping control: fast-GC and fast-GC/MS determination of β-adrenoceptor ligands and diuretics. J. Sep. Sci.29 , 2765–2771 (2006).
  • Sigmund G , HorningS, SeinschI, SchänzerW. Confirmation of clenbuterol-Reextraction with hydrochloric acid. In: Recent Advances in Doping Analysis. Mareck-Engelke U (Ed.). Sport und Buch Strauss, Köln, Germany 129–133 (1998).
  • Spisso BF , LopesCC, MarquesMA, NetoFR. Determination of β2-agonists in bovine urine: comparison of two extraction/clean-up procedures for high-resolution gas chromatography-mass spectrometry analysis. J. Anal. Toxicol.24 , 146–152 (2000).
  • Henze MK . Screening auf β2-sympathomimetika in der doping-analytik: entwicklung und erprobung eines gaschromatographisch massenspektrometrischen analyseverfahrens für human-urin. Thesis: Mathematisch-Naturwissenschaftlich-Technische Fakultät. Martin-Luther-Universität, Halle-Wittenberg, Germany (2001).
  • Amendola L , ColamoniciC, RossiF, BotreF. Determination of clenbuterol in human urine by GC-MS-MS-MS: confirmation analysis in antidoping control. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.773 , 7–16 (2002).
  • Van Eenoo P , DelbekeFT, DeprezP. Detection of inhaled clenbuterol in horse urine by GC/MS2. Biomed. Chromatogr.16 , 475–481 (2002).
  • Pereira HM , MarquesMA, TalhasIB, Aquino Neto FR. Analysis of androgenic steroids, β-2 agonists and other substances by GC-MS-ITD. In: Recent Advances in Doping Analysis. Schänzer W et al.(Eds). Sport und Buch Strauß, Köln, Germany, 259–263 (2003).
  • Anielski P . Langzeitnachweis anaboler steroidhormone. Thesis: Fakultät Mathematik und Naturwissenschaften. Technische Universität Dresden, Dresden, Germany 205 (2007).
  • Schlupp A , AnielskiP, ThiemeD, MullerRK, MeyerH, EllendorffF. The β-agonist clenbuterol in mane and tail hair of horses. Equine Vet. J.36 , 118–122 (2004).
  • Blanchflower WJ , HewittSA, CannavanA, ElliottCT, KennedyDG. Detection of clenbuterol residues in bovine liver, muscle, retina and urine using gas chromatography/mass spectrometry. Biol. Mass Spectrom.22 , 326–330 (1993).
  • Guan F , UbohCE, SomaLRet al. Quantification of clenbuterol in equine plasma, urine and tissue by liquid chromatography coupled on-line with quadrupole time-of-flight mass spectrometry. Rapid Commun. Mass Spectrom. 16 , 1642–1651 (2002).
  • Bazylak G , NagelsLJ. Integrated acquisition of analytical and biopharmaceutical screening data for b-adrenergic-drugs employing diversified macrocycle supported potentiometric detection in HPLC systems. Curr. Med. Chem.9 , 1547–1566 (2002).
  • Polettini A , MontagnaM, HogendoornEA, DijkmanE, VanzoonenP, VanginkelLA. Applicability of coupled-column liquid-chromatography to the analysis of b-agonists in urine by direct sample injection .1. Development of a single-residue reversed-phase liquid-chromatography UV method for clenbuterol and selection of chromatographic conditions suitable for multi-residue analysis. J. Chromatogr. A 695 , 19–31 (1995).
  • Wen Y , WangY, FengYQ. Extraction of clenbuterol from urine using hydroxylated poly(glycidyl methacrylate-co-ethylene dimethacrylate) monolith microextraction followed by high-performance liquid chromatography determination. J. Sep. Sci.30 , 2874–2880 (2007).
  • Zhang Y , ZhangZ, SunY, WeiY. Development of an analytical method for the determination of β2-agonist residues in animal tissues by high-performance liquid chromatography with on-line electrogenerated [Cu(HIO6)2]5- -luminol chemiluminescence detection. J. Agric. Food Chem.55 , 4949–4956 (2007).
  • Thevis M , OpfermannG, SchänzerW. Liquid chromatography/electrospray ionization tandem mass spectrometric screening and confirmation methods for β2-agonists in human or equine urine. J. Mass Spectrom.38 , 1197–1206 (2003).
  • Lau JH , KhooCS, MurbyJE. Determination of clenbuterol, salbutamol, and cimaterol in bovine retina by electrospray ionization-liquid chromatography-tandem mass spectrometry. J. AOAC Int.87 , 31–38 (2004).
  • Leung GN , LeungDK, WanTS, WongCH. High throughput screening of suβ-ppb levels of basic drugs in equine plasma by liquid chromatography-tandem mass spectrometry. J. Chromatogr. A1156 , 271–279 (2007).
  • Shen S , OuyangJ, BaeyensWR, DelangheJR, YangY. Determination of b2-agonists by ion chromatography with direct conductivity detection. J. Pharm. Biomed. Anal.38 , 166–172 (2005).
  • Yuen AH , YacoubMH, SmolenskiRT. Determination of clenbuterol concentration in human blood using liquid chromatography with electrospray/ion-trap tandem mass spectrometry. Rapid Commun. Mass Spectrom.19 , 3603–3606 (2005).
  • Lehner AF , HarkinsJD, KarpiesiukWet al. Clenbuterol in the horse: confirmation and quantitation of serum clenbuterol by LC-MS-MS after oral and intratracheal administration. J. Anal. Toxicol. 25 , 280–287 (2001).
  • Thevis M , SchebalkinT, ThomasA, SchänzerW. Quantification of clenbuterol in human plasma and urine by liquid chromatography-tandem mass spectrometry. Chromatographia62 , 435–439 (2005).
  • Chen Z , ZengS, YaoT. Separation of β-receptor blockers and analogs by capillary liquid chromatography (CLC) and pressurized capillary electrochromatography (pCEC) using a vancomycin chiral stationary phase column. Pharmazie62 , 585–592 (2007).
  • Zhang D , ChengM, HyunMH, XiongZ, PanL, LiF. Enantiomeric separation of β2-agonists on macrocyclic antibiotic chiral stationary phases in high performance liquid chromatography. Pharmazie62 , 836–840 (2007).
  • Song Y , WangD, HuY, ChenX, JiaoY, HouD. Direct separation and quantitative determination of clenbuterol enantiomers by high performance liquid chromatography using an amide type chiral stationary phase. J. Pharm. Biomed. Anal.31 , 311–319 (2003).
  • Zhang XZ , GanYR, ZhaoFN. Determination of residual clenbuterol in pork meat and liver by HPLC with electrochemical detection. Yao Xue Xue Bao39 , 276–280 (2004).
  • Crescenzi C , BayoudhS, CormackPA, KleinT, EnsingK. Determination of clenbuterol in bovine liver by combining matrix solid-phase dispersion and molecular imprinted solid-phase extraction followed by liquid chromatography/electrospray ion trap multiple-stage mass spectrometry. Anal. Chem.73 , 2171–2177 (2001).
  • Bazylak G , NagelsLJ. Simultaneous high-throughput determination of clenbuterol, ambroxol and bromhexine in pharmaceutical formulations by HPLC with potentiometric detection. J. Pharm. Biomed. Anal.32 , 887–903 (2003).
  • Brambilla G , FioriM, RizzoB, CrescenziV, MasciG. Use of molecularly imprinted polymers in the solid-phase extraction of clenbuterol from animal feeds and biological matrices. J. Chromatogr. B Biomed. Sci. Appl.759 , 27–32 (2001).
  • Blomgren A , BerggrenC, HolmbergA, LarssonF, SellergrenB, EnsingK. Extraction of clenbuterol from calf urine using a molecularly imprinted polymer followed by quantitation by high-performance liquid chromatography with UV detection. J. Chromatogr. A975 , 157–164 (2002).
  • Hogendoorn EA , van Zoonen P, Polettini A, Montagna M. Hyphenation of coupled-column liquid chromatography and thermospray tandem mass spectrometry for the rapid determination of β2-agonist residues in bovine urine using direct large-volume sample injection. Set-up of single-residue methods for clenbuterol and salbutamol. J. Mass Spectrom.31 , 418–426 (1996).
  • Dickson LC , MacNeilJD, LeeS, FesserAC. Determination of β-agonist residues in bovine urine using liquid chromatography–tandem mass spectrometry. J. AOAC Int.88 , 46–56 (2005).
  • Fesser AC , DicksonLC, MacNeilJD, PattersonJR, LeeS, GedirR. Determination of β-agonists in liver and retina by liquid chromatography–tandem mass spectrometry. J. AOAC Int.88 , 61–69 (2005).
  • Widstrand C , LarssonF, FioriM, CivitarealeC, MiranteS, BrambillaG. Evaluation of MISPE for the multi-residue extraction of β-agonists from calves urine. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.804 , 85–91 (2004).
  • Joyce C , SmythWF, RamachandranVN, O‘KaneE, CoulterDJ. The characterisation of selected drugs with amine-containing side chains using electrospray ionisation and ion trap mass spectrometry and their determination by HPLC-ESI-MS. J. Pharm. Biomed. Anal.36 , 465–476 (2004).
  • van Hout MW , HoflandCM, NiederlanderHA, de Jong GJ. On-line coupling of solid-phase extraction with mass spectrometry for the analysis of biological samples. II. Determination of clenbuterol in urine using multiple-stage mass spectrometry in an ion-trap mass spectrometer. Rapid Commun. Mass Spectrom.14 , 2103–2111 (2000).
  • van Hout MW , NiederlanderHA, de Zeeuw RA, de Jong GJ. Ion suppression in the determination of clenbuterol in urine by solid-phase extraction atmospheric pressure chemical ionisation ion-trap mass spectrometry. Rapid Commun. Mass Spectrom.17 , 245–250 (2003).
  • Huang JF , ZhangHJ, LinB, YuQW, FengYQ. Multiresidue analysis of β-agonists in pork by coupling polymer monolith microextraction to electrospray quadrupole time-of-flight mass spectrometry. Rapid Commun. Mass Spectrom.21 , 2895–2904 (2007).
  • Lin Z , ZhangS, ZhaoM, YangC, ChenD, ZhangX. Rapid screening of clenbuterol in urine samples by desorption electrospray ionization tandem mass spectrometry. Rapid Commun. Mass Spectrom.22 , 1882–1888 (2008).
  • Shi Y , HuangY, DuanJ, ChenH, ChenG. Field-amplified on-line sample stacking for separation and determination of cimaterol, clenbuterol and salbutamol using capillary electrophoresis. J. Chromatogr. A1125 , 124–128 (2006).
  • Sirichai S , KhanatharanaP. Rapid analysis of clenbuterol, salbutamol, procaterol, and fenoterol in pharmaceuticals and human urine by capillary electrophoresis. Talanta76 , 1194–1198 (2008).
  • Zhou S , WangY, De Beer T et al. Simultaneous separation of eight β-adrenergic drugs using titanium dioxide nanoparticles as additive in capillary electrophoresis. Electrophoresis29 , 2321–2329 (2008).
  • Chen Q , FanLY, ZhangW, CaoCX. Separation and determination of abused drugs clenbuterol and salbutamol from complex extractants in swine feed by capillary zone electrophoresis with simple pretreatment. Talanta76 , 282–287 (2008).
  • Vela J , YanesEG, StalcupAM. Quantitative determination of clenbuterol, salbutamol and tulobuterol enantiomers by capillary electrophoresis. Fresenius J. Anal. Chem.369 , 212–219 (2001).
  • Kim KH , KimHJ, JeunEYet al. Chiral separation of β2-agonists by capillary electrophoresis using hydroxypropyl-α-cyclodextrin as a chiral selector. Arch. Pharm. Res. 24 , 281–285 (2001).
  • Toussaint B , HubertPH, TjadenUR, van der Greef J, Crommen J. Enantiomeric separation of clenbuterol by transient isotachophoresis-capillary zone electrophoresis-UV detection new optimization technique for transient isotachophoresis. J. Chromatogr. A871 , 173–180 (2000).
  • Anurukvorakun O , SuntornsukW, SuntornsukL. Factorial design applied to a non-aqueous capillary electrophoresis method for the separation of β-agonists. J. Chromatogr. A1134 , 326–332 (2006).
  • Garcia-Ruiz C , MarinaML. Fast enantiomeric separation of basis drugs by electrokinetic chromatography. Application to the quantitation of terbutaline in a pharmaceutical preparation. Electrophoresis22 , 3191–3197 (2001).
  • Toussaint B , PalmerM, ChiapP, HubertP, CrommenJ. On-line coupling of partial filling-capillary zone electrophoresis with mass spectrometry for the separation of clenbuterol enantiomers. Electrophoresis22 , 1363–1372 (2001).
  • Huikko K , KotiahoT, KostiainenR. Effects of nebulizing and drying gas flow on capillary electrophoresis/mass spectrometry. Rapid Commun. Mass Spectrom.16 , 1562–1568 (2002).
  • Zhou J , XuX, WangY. Competitive immunoassay for clenbuterol using capillary electrophoresis with laser-induced fluorescence detection. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.848 , 226–231 (2007).
  • Berggren C , BayoudhS, SherringtonD, EnsingK. Use of molecularly imprinted solid-phase extraction for the selective clean-up of clenbuterol from calf urine. J. Chromatogr. A889 , 105–110 (2000).
  • Koster EH , CrescenziC, den Hoedt W, Ensing K, de Jong GJ. Fibers coated with molecularly imprinted polymers for solid-phase microextraction. Anal. Chem.73 , 3140–3145 (2001).
  • Katz SE , SiewierskiM. Drug residue analysis using immunoaffinity chromatography. J. Chromatogr.624 , 403–409 (1992).
  • Geyer H , Mareck-EngelkeU, SchänzerW, DonikeM. Simple purification of urine samples for improved detection of anabolic and endogenous steroids. In: Recent Advances in Doping Analysis. Donike M, Geyer H, Gotzmann A, Mareck-Engelke U, Rauth S (Eds). Sport und Buch Strauss, Köln, Germany, 97–104 (1994).
  • Silva AI Jr, Pereira HM, Casilli A, Aquino Neto FR. Analytical challenges in doping control: GCxGC: is it an option? In: Recent Advances in Doping Analysis. Schänzer W, Geyer H, Gotzmann A, Mareck U (Eds). Sport und Buch Strauß, Köln, Germany, 217–226 (2007).
  • Silva AI Jr, Pereira HM, Casilli A, Conceicao FC, Aquino Neto FR. Analytical challenges in doping control: comprehensive two-dimensional gas chromatography with time of flight mass spectrometry, a promising option. J. Chromatogr. A1216(14) , 2913–2922 (2008).
  • Fiori M , CartoniC, BoccaB, BrambillaG. The use of nonendcapped C18 columns in the cleanup of clenbuterol and a new adrenergic agonist from bovine liver by gas chromatography-tandem mass spectrometry analysis. J. Chromatogr. Sci.40 , 92–96 (2002).
  • Lai WH , FungDY, XuY, XiongYH. Screening procedures for clenbuterol residue determination in raw swine livers using lateral-flow assay and enzyme-linked immunosorbent assay. J. Food Prot.71 , 865–869 (2008).
  • Lin LA , TomlinsonJA, SatzgerRD. Detection of clenbuterol in bovine retinal tissue by high-performance liquid chromatography with electrochemical detection. J. Chromatogr. A 762 , 275–280 (1997).
  • Pfaffl MW , van Ginkel LA, McEvoy JD, Maghuin-Rogister G, Meyer HH. Development of clenbuterol reference materials: lyophilized bovine eye samples free of clenbuterol (CRM 673) and containing clenbuterol (CRM 674). Part 1. Preparation, homogeneity and stability. Fresenius J. Anal. Chem.371 , 1086–1091 (2001).
  • Gaillard Y , PepinG. Testing hair for pharmaceuticals. J. Chromatogr. B Biomed. Sci. Appl.733 , 231–246 (1999).
  • Blank DL , KidwellDA. Decontamination procedures for drugs of abuse in hair: are they sufficient?. Forensic Sci. Int.70 , 13–38 (1995).
  • Gleixner A , SauerweinH, MeyerHH. Probenecid, sulfinpyrazone and pyrazinamide do not inhibit urinary excretion of the β2-adrenoceptor agonist clenbuterol in cattle. Food Addit. Contam.13 , 603–608 (1996).
  • Hernandez-Carrasquilla M . External contamination of bovine hair with β2-agonist compounds: evaluation of decontamination strategies. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.767 , 235–243 (2002).
  • Deng XS , KurosuA, PounderDJ. Detection of anabolic steroids in head hair. J. Forensic Sci.44 , 343–346 (1999).
  • Melwanki MB , FuhMR. Dispersive liquid–liquid microextraction combined with semi-automated in-syringe back extraction as a new approach for the sample preparation of ionizable organic compounds prior to liquid chromatography. J. Chromatogr. A1198–1199, 1–6 (2008).
  • Mayr A . Illegal antibiotics and hormones in swine raising. Is the meat a health risk?. MMW Fortschr. Med.143 , 16 (2001).
  • Paige C . The issues of residues and human health. J. Am. Vet. Med. Assoc.213 , 1735–1736 (1998).
  • Polettini A , RicossaMC, GroppiA, MontagnaM. Determination of clenbuterol in urine as its cyclic boronate derivative by gas chromatography–mass spectrometry. J. Chromatogr.564 , 529–535 (1991).
  • Kintz P , Dumestre-TouletV, JameyC, CirimeleV, LudesB. Doping control for β-adrenergic compounds through hair analysis. J. Forensic Sci.45 , 170–174 (2000).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.